1. Home
  2. LEG vs DVAX Comparison

LEG vs DVAX Comparison

Compare LEG & DVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Leggett & Platt Incorporated

LEG

Leggett & Platt Incorporated

HOLD

Current Price

$12.30

Market Cap

1.6B

ML Signal

HOLD

Logo Dynavax Technologies Corporation

DVAX

Dynavax Technologies Corporation

HOLD

Current Price

$15.41

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEG
DVAX
Founded
1883
1996
Country
United States
United States
Employees
17700
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
LEG
DVAX
Price
$12.30
$15.41
Analyst Decision
Hold
Hold
Analyst Count
4
5
Target Price
$10.50
$26.50
AVG Volume (30 Days)
1.7M
4.9M
Earning Date
02-12-2026
02-19-2026
Dividend Yield
1.66%
N/A
EPS Growth
N/A
N/A
EPS
1.61
N/A
Revenue
$4,172,899,999.00
$330,514,000.00
Revenue This Year
N/A
$24.63
Revenue Next Year
N/A
$15.85
P/E Ratio
$7.49
N/A
Revenue Growth
N/A
26.73
52 Week Low
$6.48
$9.20
52 Week High
$12.09
$15.49

Technical Indicators

Market Signals
Indicator
LEG
DVAX
Relative Strength Index (RSI) 75.23 88.47
Support Level $10.78 $10.78
Resistance Level $11.84 $15.45
Average True Range (ATR) 0.31 0.10
MACD 0.06 0.15
Stochastic Oscillator 97.55 98.41

Price Performance

Historical Comparison
LEG
DVAX

About LEG Leggett & Platt Incorporated

Leggett & Platt Inc designs and produces engineered components and products found in homes and automobiles. It operates its business through three segments namely Bedding Products, Specialized Products, and Furniture, Flooring, and Textile Products. It generates the majority of its revenue from Bedding Products. Serving a broad suite of customers around the world, Leggett & Platt's products include bedding components, automotive seat support, and lumbar systems, specialty bedding foam and private label finished mattresses, components for home furniture, and work furniture, flooring underlayment, adjustable beds, and various other products.

About DVAX Dynavax Technologies Corporation

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

Share on Social Networks: